DLD Antikörper (Middle Region)
Kurzübersicht für DLD Antikörper (Middle Region) (ABIN631024)
Target
Alle DLD Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- DLD antibody was raised against the middle region of DLD
-
Aufreinigung
- Affinity purified
-
Immunogen
- DLD antibody was raised using the middle region of DLD corresponding to a region with amino acids AGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
DLD Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this DLD antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of DLD antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- DLD (Dihydrolipoamide Dehydrogenase (DLD))
-
Andere Bezeichnung
- DLD
-
Hintergrund
- DLD is the L protein of the mitochondrial glycine cleavage system. The L protein, also named dihydrolipoamide dehydrogenase, is also a component of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acide dehydrogenase complex. Mutations in this gene have been identified in patients with E3-deficient maple syrup urine disease and lipoamide dehydrogenase deficiency.
-
Molekulargewicht
- 56 kDa (MW of target protein)
-
Pathways
- Ribonucleoside Biosynthetic Process, Cell RedoxHomeostasis
Target
-